Dr. Fatih Inci is an Assistant Professor at the Institute of Materials Science and Nanotechnology, Bilkent University – UNAM. Before his current role, Dr. Inci was working as a research scientist at the Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford University School of Medicine (Palo Alto, CA, USA) (2016-2019), where he was leading and working with a group of researchers to develop micro- and nano-technologies for biomedical and bioengineering applications. Dr. Inci completed his postdoctoral training at Stanford University School of Medicine (2014-2016) and Harvard Medical School-Brigham & Women’s Hospital (BWH) (Boston, MA, USA) (2013-2014). He received his Ph.D. degree at the Department of Molecular Biology-Genetics & Biotechnology from Istanbul Technical University (Turkey) in 2013. During his doctoral studies, he was appointed as a visiting scientist at School of Biotechnology and Biomolecular Sciences, University of New South Wales; and Institute for Nanoscale Technology, University of Technology Sydney (Sydney, NSW, Australia) in 2010. In addition, he worked as a research scholar at Harvard Medical School-BWH and Harvard-Massachusetts Institute of Technology (MIT) - Health Sciences and Technology (Boston, MA, USA) (2011-2012). Dr. Inci holds a Science Baccalaureate Degree (B.Sc.) from the Department of Molecular Biology and Genetics, Istanbul University (Turkey), and he also studied as an Erasmus/Socrates Exchange student at the Department of Biology, University of Groningen (Netherlands).
Dr. Inci has authored papers in interdisciplinary journals, including PNAS, ACS Nano, Advanced Science, Light: Science & Applications, Applied Materials Today, Small, Lab on a chip, and Biomacromolecules. He also reviewed the literature comprehensively and published papers in Chemical Reviews, Advanced Drug Delivery Reviews, Biotechnology Advances, Annual Review of Medicine, Chemical Society Reviews, Materials Today, and Trends in Biotechnology. Besides his journal publications, he has contributed to the publication of 7 book chapters (including 3 chapters in press) and 3 editorial/perspective papers. He is also editing 3 scientific books in Springer Press and World Scientific. He has also 7 U.S. and International patents on biosensing, medical diagnostics, and micro/nano-scale technologies. Some of them have already been licensed by companies to produce commercial products (CSI-QTM and NGDETM).
In addition, many of his papers were featured on the cover of Advanced Science (2 covers), Small, and Chemical Society Reviews journals and have been also highlighted in National Institutes of Health (NIH)–National Institute of Biomedical Imaging and Bioengineering, Science AAAS, Nature Medicine, American Institute of Physics, Journal of the American Medical Association (JAMA), Newsweek, Popular Science, The London Economic, Boston University, BWH, Stanford University, Johns Hopkins, and so on. Dr. Inci has also chaired sessions and given invited talks at national and international conferences (60+) around the world.
Dr. Inci has been awarded various scholarships and grants from Turkey Scientific and Technological Research Society (TUBITAK), Canary Center at Stanford with Partnership of OHSU Knight Cancer Institute and Cancer Research UK, European Molecular Biology Organization-European Science Foundation, American Chemical Society, Istanbul University, and Istanbul Technical University. His research along with his collaborators were awarded Biomedical Research Institute Translatable Technologies & Care Innovation Award and BRIght Future Prize from Harvard-BWH; and three seed grants from Canary Center and The Precision Health and Integrated Diagnostics Center at Stanford.
Dr. Inci has garnered international acclaim for numerous original contributions within the emergent fields of micro/nanoscale technology, biomedical engineering, medicine, chemistry, and materials science. His research comes from a hybridization of innovative research and in-depth understanding of multidisciplinary scientific area, where he harmonizes microfluidics, precision health, medical diagnostics, nanoplasmonics, biosensing systems, surface chemistry approaches, bio-inspired materials and systems, mobile health, nanomechanical strategies, and drug delivery. In this respect, he has denoted non-conventional and innovative solutions to address challenges in increasingly prevalent diseases, such as infectious diseases, acute/chronic conditions, and cancer.
More information: incilab.bilkent.edu.tr